If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Maria Vittoria Dieci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
Biomarkers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2020

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Prat, A., Pascual, T., De Angelis, C., Gutierrez, C., Llombart-Cussac, A., Wang, T., Cortés, J., Rexer, B., Paré, L., Forero, A., Wolff, A. C., Morales, S., Adamo, B., Brasó-Maristany, F., Vidal, M., Veeraraghavan, J., Krop, I., Galván, P., Pavlick, A. C., Bermejo, B. & 15 others, Izquierdo, M., Rodrik-Outmezguine, V., Reis-Filho, J. S., Hilsenbeck, S. G., Oliveira, M., Dieci, M. V., Griguolo, G., Fasani, R., Nuciforo, P., Parker, J. S., Conte, P., Schiff, R., Guarneri, V., Osborne, C. K. & Rimawi, M. F., Jan 1 2020, In : Journal of the National Cancer Institute. 112, 1, p. 46-54 9 p.

Research output: Contribution to journalArticle

Confidence Intervals
Breast Neoplasms
Drug Therapy
Disease-Free Survival
Enzyme-Linked Immunosorbent Assay

Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease

Dieci, M. V., Tsvetkova, V., Griguolo, G., Miglietta, F., Mantiero, M., Tasca, G., Cumerlato, E., Giorgi, C. A., Giarratano, T., Faggioni, G., Falci, C., Vernaci, G., Menichetti, A., Mioranza, E., Di Liso, E., Frezzini, S., Saibene, T., Orvieto, E. & Guarneri, V., 2019, In : Frontiers in Oncology. 9, p. 1-9 9 p.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Androgen Receptors
Disease-Free Survival
Therapeutics
Survival Rate

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Open Access
Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Confidence Intervals
Proportional Hazards Models

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

Dieci, M. V., Conte, P., Bisagni, G., Brandes, A. A., Frassoldati, A., Cavanna, L., Musolino, A., Giotta, F., Rimanti, A., Garrone, O., Bertone, E., Cagossi, K., Sarti, S., Ferro, A., Piacentini, F., Maiorana, A., Orvieto, E., Sanders, M., Miglietta, F., Balduzzi, S. & 2 others, D'Amico, R. & Guarneri, V., Mar 1 2019, In : Annals of Oncology. 30, 3, p. 418-423 6 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Disease-Free Survival
Breast Neoplasms
Hematoxylin
Eosine Yellowish-(YS)

BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis

Vernaci, G., Dieci, M. V., Manfrin, S., Mantiero, M., Falci, C., Faggioni, G., Mioranza, E., Menichetti, A., Tasca, G., Griguolo, G., Miglietta, F., Di Liso, E., Saibene, T., Michieletto, S., Ghiotto, C., Conte, P. & Guarneri, V., Oct 2019, In : Breast. 47, p. 77-84 8 p.

Research output: Contribution to journalArticle